hormone replacement therapy that combines estrogen and progestin doubles a woman 's risk of breast cancer , a british study of more than a million women has found .
a major british study has added to the evidence that hormone replacement therapy increases the risk of breast cancer , especially when women receive a combination of estrogen and progestin .